Immix Biopharma, Inc. · NASDAQ:IMMX

Saturn V Capital Management LP reported a 6.97% stake in Immix Biopharma, Inc. (Schedule 13G)

Event Dec 26, 2025 · Filed Feb 17, 2026

Saturn V Capital Management LP reported a 6.97% stake in Immix Biopharma, Inc., 3,693,585 shares, as a passive investor on Dec 26, 2025. Filed Feb 17, 2026 (Schedule 13G).

Stake
6.97%
Shares
3,693,585
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Saturn V Capital Management LP6.97%3,693,585
Xiaoying Tian6.97%3,693,585

Source

View original at SEC

Related